Coagulation factor deficiencies and pregnancy loss

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 2, 2003, Pages 171-174

  Inbal, Aida ^a,b   Muszbek, Laszlo ^c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Afibrinogenemia; Factor XIII deficiency; Miscarriages

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRINOGEN; FRESH FROZEN PLASMA;

AFIBRINOGENEMIA; AUTOSOMAL RECESSIVE DISORDER; BLEEDING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR DEFICIENCY; CRYOPRECIPITATE; DRUG HALF LIFE; DYSFIBRINOGENEMIA; FEMALE; FETUS WASTAGE; FIBRINOGEN DEFECT; HUMAN; HYPOFIBRINOGENEMIA; INFUSION; NIDATION; PARTIAL THROMBOPLASTIN TIME; PLASMA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RECURRENT ABORTION; REVIEW; SPONTANEOUS ABORTION; THROMBIN TIME; WOUND HEALING;

ABORTION, SPONTANEOUS; AFIBRINOGENEMIA; COAGULATION PROTEIN DISORDERS; FACTOR XIII DEFICIENCY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 0037394680     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38832     Document Type: Review

References (37)

1. Schwartz ML, Pizzo SV, McKee PA. Human factor XIII from plasma and platelets. J Biol Chem 1973;248:1395-1407
2. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999;94:271-305
3. Fisher S, Rikover M, Naor S. Factor 13 deficiency with severe hemorrhagic diathesis. Blood 1966;28:34-39
4. Anwar T, Miloszewski K. Factor XIII deficiency. Br J Haematol 1999;107:468-484
5. Ádány R, Muszbek L. Immunohistochemical detection of Factor XIII subunit a in histiocytes of human uterus. Histochemistry 1989;91:169-174
6. Asahina T, Kobayashi T, Okada Y, et al. Studies on the role of adhesive proteins in maintaining pregnancy. Horm Res 1998;50(Suppl 2):37-45
7. Ádány R, Glukhova M, Kabakov AY, et al. Characterization of connective tissue cells containing factor XIII subunit a. J Clin Pathol 1988;41:49-56
8. Kappelmayer J, Bacsko G, Kelemen E, et al. Onset and distribution of factor XIII-containing cells in the mesenchyme of chorionic villi during early phase of human placentation. Placenta 1994;15:613-623
9. Muszbek L, Ádány R, Kávai M, et al. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit A antigen and transglutaminase activity. Thromb Haemost 1988;59:231-235
10. Rodeghiero F, Castaman GC, Di Bona E, et al. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitute therapy. Blut 1987;55:45-48
11. Boda Z, Pfliegler G, Muszbek L, et al. Congenital factor XIII deficiency with multiple benign breast tumors and successful pregnancy with substitutive therapy. Haemostasis 1989;19:348-352
12. Kobayashi T, Terao T, Kojima T, et al. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990;29:235-238
13. Burrows RF, Ray, JG, Burrows EA. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Survey 2000;55:103-8
14. Wartiovaara J, Leivo I, Virtanen I, et al. Cell surface and extracellular matrix glycoprotein fibronectin. Expression in embryogenesis and in teratocarcinoma differentiation. Ann NY Acad Sci 1978;312:132-141
15. Vicovac L, Aplin JD. Epithellal-mesenchymal transition during trophoblast differentiation. Acta Anat 1966;156:202-216
16. Kobayashi T, Asahina T, Okada Y, et al. Studies on the localization of adhesive proteins associated with the development of extravillous cytotrophoblast. Trophoblast Res 1999;13:35-53
17. Asahina T, Kobayashi T, Okada Y, et al. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 2000;21:388-393
18. Brackmann HH, Egbring R, Feister A, et al. Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: A crossover randomized trial. Thromb Haemost 1995;74:622-625
19. Mikkola H, Muszbek L, Laiho E, et al. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood 1997;89:1279-1287
20. Hayano Y, Ima N, Kasaraura T. Studies on the physiologic changes of blood coagulation factor XIII during pregnancy and their significance. Acta Obstet Gynaecol Jpn 1982;34:469-477
21. Nossel HL, Lanzkowsky P, Levy S, et al. A study of coagulation levels in women during labor and their newborn infants. Thromb Diath Haemorrhag 1966;16:185-197
22. Biland L, Duckert F. Coagulation factors in the newborn and his mother. Thromb Diath Haemorrhag 1973;29:644-651
23. Coopland A, Alkjaersig N, Fletcher AP. Reduction in plasma factor XIII (fibrin stabilizing factor) concentration during pregnancy. L Lab Clin Med 1969;73:144-153
24. van Wersch JW, Vooijs ME, Ubachs JM. Coagulation factor XIII in pregnant smokers and non-smokers. Int J Clin Lab Res 1997;27:68-71
25. Stirling Y, Woolf L, North WRS, et al. Haemostasis in normal pregnancy. Thromb Haemost 1984;52:176-182
26. Ogasawara MS, Aoki K, Katano K, et al. Factor XII but not protein C, protein S, antithrombin III, or factor VIII is a predictor of recurrent miscarriage. Fertil Steril 2001;75:916-919
27. Galanakis DK. Fibrinogen anomalies and disease. A clinical update. Hematol Oncol Clin N Am 1992;6:1171-1187
28. Doolittle, RF. The molecular biology of fibrin. In: Stamatoyannopoulos GS, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases. Philadelphia, PA: WB Saunders; 1994:701-723
29. Bennett JS. Integrin structure and function in hemostasis and thrombosis. Ann NY Acad Sci 1991;614:214-228
30. Mosesson MW. Dysfibrinogenemia and thrombosis. Semin Thromb Hemost 1999;25:311-319
31. Ridgway, HJ, Brennan, SO, Faed, JM, George, PM. Fibrinogen Otago: a major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Br J Haematol 1997;98:632-639
32. Suh TT, Holmback K, Jensen N, et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 1995;9:2020-2033
33. Inamoto Y, Terao T. First report of a case of congenital afibrinogenemia with successful delivery. Am J Obstet Gynecol 1985;153:803-804
34. Gilabert J, Reganon E, Vila V, et al. Congenital hypofibrino-genemia and pregnancy: obstetric and hematological management. Gynecol Obstet Invest 1987;24:271-276
35. Ingram GIC, McBrien DJ, Spencer H. Fatal pulmonary erabolus in congenital fibrinopenia. Report of two cases. Acta Hematol 1966;35:56-62
36. MacKinnon HH, Fekete JF. Congenital afibrinogenemia: vascular changes and multiple thromboses mduced by fibrinogen infusions and contraceptive medication. J Can Med Assoc 1971;140:597-599
37. Beck EA. Congenital abnormalities of fibrinogen. Clin Haematol 1979;8:169-181